Costs of schizophrenia

Psychiatry

Volumn 4, Issue 10, 2005, Pages 33-35

  Knapp, Martin ^a  

^a LONDON SCHOOL OF ECONOMICS   (United Kingdom)

Author keywords

atypical antipsychotics; cost effectiveness; costs; in patient; medication adherence; relapse; schizophrenia

Indexed keywords

EID: 34848924408     PISSN: 14761793     EISSN: None     Source Type: Journal    
DOI: 10.1383/psyt.2005.4.10.33     Document Type: Article

References (15)

1. Knapp M., Mangalore R., and Simon J. Global costs of schizophrenia. Schiz Bull 30 (2004) 279-293
2. Rice D., and Miller L. The economic burden of schizophrenia. In: Moscarelli M., et al. (Ed). Handbook of mental health economics and health policy (1996), Wiley, Chichester
3. Weiden P., and Olfson M. Cost of relapse in schizophrenia. Schiz Bull 21 (1995) 419-429
4. Knapp M., King D., Pugner K., and Lapuerta P. Non-adherence to antipsychotic medication regimens: associations with resource use and costs. Br J Psychiatry 184 (2004) 509-516
5. Kemp R., Hayward P., Applewhaite G., et al. Compliance therapy in psychotic patients: randomised control trial. BMJ 312 (1996) 345-349
6. Healey A., Knapp M., Astin J., et al. Cost-effectiveness evaluation of compliance therapy for people with psychoses. Br J Psychiatry 172 (1998) 420-424
7. Almond S., Knapp M., Francois C., Toumi M., and Brugha T. Relapse in schizophrenia: costs, clinical outcomes and quality of life. Br J Psychiatry 184 (2004) 346-351
8. McDaid D., and Thornicroft G. Balancing institutional and community-based care. Policy Brief from the WHO European Observatory on Health Systems and Policies (2004)
9. Kaye J., Bradbury B., and Jick H. Changes in antipsychotic drug prescribing by general practitioners in the UK from 1991 to 2000: a population-based observational study. Br J Clin Pharmacol 56 (2003) 569-575
10. National Institute for Clinical Excellence. Schizophrenia: core interventions in the treatment and management of schizophrenia in primary and secondary care. Clinical Guideline 1 (2002), NICE, London
11. King D, Knapp M. Changing patterns of atypical and typical antipsychotic prescribing by general practitioners in the UK during the 1990s. Submitted.
12. Purcell H., and Lewis S. Postcode prescribing in psychiatry. Psychiatric Bull 24 (2000) 420-422
13. Davis J., Chen N., and Glick I. A meta-analysis of the efficacy of second-generation anti-psychotics. Arch Gen Psychiatry 60 (2003) 553-564
14. Basu A. Cost-effectiveness analysis of pharmacological treatments in schizophrenia: critical review of results and methodological issues. Schiz Res 71 (2004) 445-462
15. Rosenheck R., Perlick D., Bingham S., et al. Effectiveness and cost of olanzapine and haloperidol in the treatment of schizophrenia: a randomized controlled trial. JAMA 290 (2004) 2693-2702